Fig. 2

FSTL1 predicts worse outcome in cSCC patients. (A) Tumor size in high vs. low FSTL1 groups. (B) Local infiltration in high vs. low FSTL1 groups. (C–I) FSTL1 and ZEB1 expression correlation in CESC, ESCA, HNSC, LUSC, SKCM and skin (exposed/non-exposed). (J) FSTL1 and ZEB1 correlation in cSCC tissues. (K–L) FSTL1 and ZEB1 immunohistochemistry and heatmap in tissues, scale bars 50 μm. Data were presented as the mean ± SD. (ns, non-significant; *p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001)